Argenx SE OTC Stock Top Insiders

ARGNF Stock  USD 870.00  0.00  0.00%   
Argenx SE employs about 650 people. The company is managed by 10 executives with a total tenure of roughly 1517 years, averaging almost 151.0 years of service per executive, having 65.0 employees per reported executive. Examination of Argenx SE's management performance can provide insight into the company performance.
Karl Gubitz  Insider
Chief Officer
Beth DelGiacco  Insider
VP Relations
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in argenx SE. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in state.

Argenx SE Management Team Effectiveness

The company has return on total asset (ROA) of (0.1649) % which means that it has lost $0.1649 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3064) %, meaning that it generated substantial loss on money invested by shareholders. Argenx SE's management efficiency ratios could be used to measure how well Argenx SE manages its routine affairs as well as how well it operates its assets and liabilities.

argenx SE Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. argenx SE Price Series Summation is a cross summation of Argenx SE price series and its benchmark/peer.

Argenx SE Notable Stakeholders

An Argenx SE stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Argenx SE often face trade-offs trying to please all of them. Argenx SE's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Argenx SE's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Karl GubitzChief OfficerProfile
Beth DelGiaccoVP RelationsProfile
Malini MoorthyG CounselProfile
EMBA MBACEO DirectorProfile
Filip BorgionsVP OperationsProfile
Pr IrCoFounder OfficerProfile
Keith WoodsChief OfficerProfile
Arjen MScVP StrategyProfile
David MDAdvisorProfile
Andria WilkGlobal QualityProfile

About Argenx SE Management Performance

The success or failure of an entity such as argenx SE often depends on how effective the management is. Argenx SE management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Argenx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Argenx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Ltd, Universit Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., University of Texas, BioWa, Inc., Cilag GmbH International, Staten Biotechnology B.V., and Shire International GmbH. argenx SE was incorporated in 2008 and is based in Breda, the Netherlands. Argen X is traded on OTC Exchange in the United States.
The data published in Argenx SE's official financial statements typically reflect Argenx SE's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Argenx SE's quantitative information. For example, before you start analyzing numbers published by Argenx accountants, it's essential to understand Argenx SE's liquidity, profitability, and earnings quality within the context of the Argenx space in which it operates.

Argenx SE Workforce Analysis

Traditionally, organizations such as Argenx SE use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Argenx SE within its industry.

Argenx SE Manpower Efficiency

Return on Argenx SE Manpower

Revenue Per Employee765K
Revenue Per Executive49.7M
Net Loss Per Employee628.1K
Net Loss Per Executive40.8M

Complementary Tools for Argenx OTC Stock analysis

When running Argenx SE's price analysis, check to measure Argenx SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Argenx SE is operating at the current time. Most of Argenx SE's value examination focuses on studying past and present price action to predict the probability of Argenx SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Argenx SE's price. Additionally, you may evaluate how the addition of Argenx SE to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stocks Directory
Find actively traded stocks across global markets